|
1
|
Rea D, Coppola G, Palma G, Barbieri A,
Luciano A, Del Prete P, Rossetti S, Berretta M, Facchini G, Perdonà
S, et al: Microbiota effects on cancer: From risks to therapies.
Oncotarget. 9:17915–17927. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan J, McKenzie C, Potamitis M, Thorburn
AN, Mackay CR and Macia L: The role of short-chain fatty acids in
health and disease. Adv Immunol. 121:91–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tian Y, Xu Q, Sun L, Ye Y and Ji G:
Short-chain fatty acids administration is protective in
colitis-associated colorectal cancer development. J Nutr Biochem.
57:103–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu X, Wu Y, He L, Wu L, Wang X and Liu Z:
Effects of the intestinal microbial metabolite butyrate on the
development of colorectal cancer. J Cancer. 9:2510–2517. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao X, Cao Y and Chen H: Profiling and
characterization of microRNAs responding to sodium butyrate
treatment in A549 cells. J Cell Biochem. 119:3563–3573. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Liu D, Zhou Y, Li Y, Xie J, Lee RJ,
Cai Y and Teng L: Silencing of Survivin Expression Leads to Reduced
Proliferation and Cell Cycle Arrest in Cancer Cells. J Cancer.
6:1187–1194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sumi T, Hirai S, Yamaguchi M, Tanaka Y,
Tada M, Yamada G, Hasegawa T, Miyagi Y, Niki T, Watanabe A, et al:
Survivin knockdown induces senescence in TTF 1-expressing,
KRAS-mutant lung adenocarcinomas. Int J Oncol. 53:33–46.
2018.PubMed/NCBI
|
|
8
|
Zhao X, Ogunwobi OO and Liu C: Survivin
inhibition is critical for Bcl-2 inhibitor-induced apoptosis in
hepatocellular carcinoma cells. PLoS One. 6:e219802011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim K, Son MY, Jung CR, Kim DS and Cho HS:
EHMT2 is a metastasis regulator in breast cancer. Biochem Biophys
Res Commun. 496:758–762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SK, Kim K, Ryu JW, Ryu TY, Lim JH, Oh
JH, Min JK, Jung CR, Hamamoto R, Son MY, et al: The novel
prognostic marker, EHMT2, is involved in cell proliferation via
HSPD1 regulation in breast cancer. Int J Oncol. 54:65–76.
2018.PubMed/NCBI
|
|
11
|
Ryu TY, Kim K, Kim SK, Oh JH, Min JK, Jung
CR, Son MY, Kim DS and Cho HS: SETDB1 regulates SMAD7 expression
for breast cancer metastasis. BMB Rep. 52:139–144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryu TY, Kim K, Son MY, Min JK, Kim J, Han
TS, Kim DS and Cho HS: Downregulation of PRMT1, a histone arginine
methyltransferase, by sodium propionate induces cell apoptosis in
colon cancer. Oncol Rep. 41:1691–1699. 2019.PubMed/NCBI
|
|
13
|
Kim DS, Ryu JW, Son MY, Oh JH, Chung KS,
Lee S, Lee JJ, Ahn JH, Min JS, Ahn J, et al: A liver-specific gene
expression panel predicts the differentiation status of in vitro
hepatocyte models. Hepatology. 66:1662–1674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Son MY, Jung CR, Kim DS and Cho HS:
Comparative in silico profiling of epigenetic modifiers in human
tissues. Mol Biol Rep. 45:309–314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung KB, Lee H, Son YS, Lee MO, Kim YD, Oh
SJ, Kwon O, Cho S, Cho HS, Kim DS, et al: Interleukin-2 induces the
in vitro maturation of human pluripotent stem cell-derived
intestinal organoids. Nat Commun. 9:30392018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ryu JW, Kim SK, Son MY, Jeon SJ, Oh JH,
Lim JH, Cho S, Jung CR, Hamamoto R, Kim DS, et al: Novel prognostic
marker PRMT1 regulates cell growth via downregulation of CDKN1A in
HCC. Oncotarget. 8:115444–115455. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davie JR: Inhibition of histone
deacetylase activity by butyrate. J Nutr. 133 (Suppl
7):2485S–2493S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hinnebusch BF, Meng S, Wu JT, Archer SY
and Hodin RA: The effects of short-chain fatty acids on human colon
cancer cell phenotype are associated with histone hyperacetylation.
J Nutr. 132:1012–1017. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ooi CC, Good NM, Williams DB, Lewanowitsch
T, Cosgrove LJ, Lockett TJ and Head RJ: Structure-activity
relationship of butyrate analogues on apoptosis, proliferation and
histone deacetylase activity in HCT-116 human colorectal cancer
cells. Clin Exp Pharmacol Physiol. 37:905–911. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heerdt BG, Houston MA and Augenlicht LH:
Short-chain fatty acid-initiated cell cycle arrest and apoptosis of
colonic epithelial cells is linked to mitochondrial function. Cell
Growth Differ. 8:523–532. 1997.PubMed/NCBI
|
|
21
|
Bertoli C, Skotheim JM and de Bruin RA:
Control of cell cycle transcription during G1 and S phases. Nat Rev
Mol Cell Biol. 14:518–528. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Deiry WS: p21(WAF1) Mediates Cell-Cycle
Inhibition, Relevant to Cancer Suppression and Therapy. Cancer Res.
76:5189–5191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park AM, Tsunoda I and Yoshie O: Heat
shock protein 27 promotes cell cycle progression by down-regulating
E2F transcription factor 4 and retinoblastoma family protein p130.
J Biol Chem. 293:15815–15826. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karimian A, Ahmadi Y and Yousefi B:
Multiple functions of p21 in cell cycle, apoptosis and
transcriptional regulation after DNA damage. DNA Repair (Amst).
42:63–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Emenaker NJ, Calaf GM, Cox D, Basson MD
and Qureshi N: Short-chain fatty acids inhibit invasive human colon
cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax,
p21 and PCNA protein expression in an in vitro cell culture model.
J Nutr. 131 (Suppl 11):3041S–3046S. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rephaeli A, Blank-Porat D, Tarasenko N,
Entin-Meer M, Levovich I, Cutts SM, Phillips DR, Malik Z and
Nudelman A: In vivo and in vitro antitumor activity of
butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase
inhibitor, in human prostate cancer. Int J Cancer. 116:226–235.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Edmond V, Brambilla C, Brambilla E,
Gazzeri S and Eymin B: SRSF2 is required for sodium
butyrate-mediated p21(WAF1) induction and premature senescence in
human lung carcinoma cell lines. Cell Cycle. 10:1968–1977. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cromie MM and Gao W:
Epigallocatechin-3-gallate enhances the therapeutic effects of
leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev.
2015:2173042015. View Article : Google Scholar : PubMed/NCBI
|
